Retrospective 226 patients in China, showing faster viral clearance with paxlovid. Age range and severity differed between groups.
time to viral-, 20.0% lower, relative time 0.80, p < 0.001, treatment 17, control 114.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
This study is excluded in the after exclusion results of meta
significant unadjusted differences between groups.
Shao et al., 28 Aug 2022, retrospective, China, peer-reviewed, median age 52.0, 12 authors, study period 6 April, 2022 - 11 May, 2022, this trial compares with another treatment - results may be better when compared to placebo.
email@example.com (corresponding author).